Table III. Statistically significant differences in residue usage at all peptide positions among shared nonamers in the IR>1.0 subsets in the indicated LCL comparisonsa.
LCL | P1 | P2 | P3 | P4 | P5 | P6 | P7 | P8 | P9 |
---|---|---|---|---|---|---|---|---|---|
6370/LG2 | A | F | G,L | K | |||||
LG2/C1R05 | A,E,N,S,K,R | D,F,M | P | P,L | L | V | |||
6370/C1R05 | E,N,S,K,R | D,E | P,K | D,E,G,I | R | K,L,V,M | |||
C1R05/P50 | R,F,L | D | P | I,D,E,W | A | K | |||
6370/P50 | A,S,F,K,L,R | A | V | K | |||||
LG2/P50 | A,S,F,K,R | A,F | K,N,L | K | K | K |
a Residues underlined or not are those that are increased in the correspondingly coded LCL.